Latest tumor Stories
- Data include results from a Phase 1 study of ABT-414 as monotherapy and in combination with radiation and/or chemotherapy in patients with newly diagnosed and recurrent/unresectable glioblastoma
Results Published in Cancer Epidemiology, Biomarkers & Prevention Demonstrate Utility of Caris Molecular Intelligence(TM) in Exploring Expression of Targetable Immune Proteins IRVING,
Research shows promise for increasing effectiveness of chemo and reduction of metastasis DALLAS, Nov.
Interim analysis of the pivotal phase III trial of Tumor Treating Fields in newly diagnosed glioblastoma (EF-14) will be presented as a late-breaking oral presentation ST.
Results presented in poster presentation beginning today and in oral presentation Saturday, November 8, at 1:40 PM at Society for Immunotherapy of Cancer annual meeting. ANN ARBOR,
Presentations at 2014 Chicago Multidisciplinary Symposium on Thoracic Oncology Point to Potential Strategies for Treatment of Small Cell, Non-small Cell, and Neuroendocrine Lung Cancers
LOS ANGELES, Oct.
Six new members elected at ABTA annual meeting Chicago, IL (PRWEB) October 22, 2014 The American Brain Tumor Association (ABTA) – the first and now
Trial Has Not Yet Reached Necessary Number of Survival Events to Report on Overall Survival Due to Longer than Expected Survival of Study Patients LOS ANGELES, Oct.
Combines NGS and FISH Testing for Comprehensive Cancer Profiling FT. MYERS, Fla., Oct. 16, 2014 /PRNewswire/ -- NeoGenomics, Inc.
- A member of the swell-mob; a genteelly clad pickpocket. Sometimes mobsman.